Treatment of UTI in Pregnancy
Pregnant women with urinary tract infections should receive 4-7 days of antibiotic therapy with nitrofurantoin, beta-lactams (ampicillin or cephalexin), or fosfomycin, with the specific duration depending on the antibiotic chosen. 1
Screening and Diagnosis
All pregnant women should be screened for bacteriuria with a urine culture at least once in early pregnancy (12-16 weeks gestation). 2, 1 This is critical because:
- Asymptomatic bacteriuria (ASB) occurs in 2-7% of pregnant women 1
- Untreated ASB increases pyelonephritis risk 20-30 fold (from 20-35% down to 1-4% with treatment) 2
- Treatment reduces preterm delivery and low birth weight 1, 2
Important caveat: A 2025 position paper 3 suggests a risk factor-based approach may be acceptable in settings with ready healthcare access, targeting screening only to high-risk women (previous UTI, diabetes, urinary abnormalities, immunosuppression, or history of preterm birth). However, the 2019 IDSA guideline 1 states this requires further validation in diverse populations before universal adoption.
First-Line Antibiotic Choices
For Asymptomatic Bacteriuria or Uncomplicated Cystitis:
Preferred agents (safe in pregnancy):
- Nitrofurantoin: 100 mg twice daily for 5-7 days 1
- Beta-lactams: Ampicillin or cephalexin (first-generation cephalosporins) for 7 days 1
- Fosfomycin trometamol: 3g single dose 4, 5
The evidence shows nitrofurantoin and beta-lactams are preferred due to established safety profiles in pregnancy, though they require longer courses than for non-pregnant women since they are less effective as short-course therapy. 1
For Acute Pyelonephritis:
Hospital-based management is mandatory for upper tract infections. 6
Empirical treatment hierarchy 6:
- First choice: Second-generation cephalosporins
- Second choice: Aminoglycosides (second/third trimester only - avoid first trimester)
- Third choice: Third-generation cephalosporins (ceftriaxone or cefixime) 7, 8
- For resistant organisms: Carbapenems if history of resistance to third-generation cephalosporins 6
After 48 hours of clinical improvement and adequate oral tolerance, switch to oral therapy to complete 7-10 days total. 6
Duration of Therapy
The 2019 IDSA guideline recommends 4-7 days rather than shorter courses (weak recommendation, low-quality evidence). 1 This represents a shift from older practices of treating through entire pregnancy.
Key nuances:
- Single-dose therapy shows lower clearance rates than 4-7 day courses 1
- A 2015 Cochrane review found 7-day nitrofurantoin more effective than single-dose for preventing low birth weight 1
- Fosfomycin single-dose shows promise but lacks robust pregnancy outcome data for pyelonephritis prevention 1
- A 2022 meta-analysis 5 found single-dose therapy (especially fosfomycin) achieved similar microbiologic cure as multiple-day therapy
Critical Management Points
Always obtain urine culture before starting empirical therapy in pregnant women with upper UTI. 6 Modify treatment based on sensitivity results if the organism shows resistance to the empirical agent. 6
Avoid these antibiotics in pregnancy:
- Fluoroquinolones (not first-line despite efficacy due to safety concerns)
- Trimethoprim-sulfamethoxazole in first and last trimesters 4
- Tetracyclines (contraindicated) 2
- Aminoglycosides in first trimester 6
Common pitfall: Do not perform routine post-treatment cultures in asymptomatic patients. 4 Only reculture if symptoms persist or recur within 2-4 weeks.
Antimicrobial Stewardship Considerations
The evidence strongly supports treating confirmed UTIs in pregnancy to prevent serious maternal-fetal complications (pyelonephritis, preterm birth, low birth weight). 1, 2 However, the shortest effective duration should be used to minimize antimicrobial resistance and adverse effects. 1
For women with recurrent UTIs in pregnancy, the approach differs from non-pregnant women - continuous or post-coital prophylaxis may be warranted after non-antimicrobial interventions fail, but this requires individualized risk-benefit assessment. 4